Director/PDMR Shareholding

RNS Number : 2105H

GlaxoSmithKline PLC

11 March 2015

 



Notification of Transactions of Directors and Persons Discharging Managerial Responsibility

GlaxoSmithKline Deferred Annual Bonus Plan

Withholding of shares to meet tax liabilities

The table below sets out changes in the interests of an Executive Director and Persons Discharging Managerial Responsibility (PDMRs) in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADSs at a fair market value of $46.73 per ADS to meet tax liabilities following the vesting of the pre-tax awards granted in 2012 under the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (DABP). The awards vested on the third anniversary of the award date which was 9 March 2015. 

	Number of ADSs withheld to meet tax liabilities following the vesting of a DABP award
Dr M Slaoui*	11,137
Mr W Louv	3,009
Mr D Troy	4,517

* Denotes an Executive Director

The Company, the Executive Director and PDMRs were advised of these transactions on 10 March, 2015.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

11 March 2015

 

END

 

 

RDSQFLFFEXFLBBZ